Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S2 pseudogene 1 (RPS2P1) is a processed pseudogene of the functional ribosomal protein S2 (RPS2) gene. It shares high sequence similarity with RPS2 but does not produce a functional protein due to sequence disruptions typical of processed pseudogenes. RPS2P1 is not involved in protein synthesis, cellular pathways, or any recognized disease processes. Such pseudogenes reflect the evolutionary history of gene families and are distributed throughout the genome as nonfunctional relics of gene duplication and retrotransposition events[3]. The functional RPS2 gene encodes a protein of the 40S ribosomal subunit[1][2][5]. RPS2P1 is one of many processed pseudogenes found for ribosomal proteins in the human genome; the term processed means it originated via reverse transcription and integration of mRNA without regulatory sequences or introns, resulting in loss of protein-coding ability[3]. There is no evidence that RPS2P1 is involved in any human diseases or is targetable by drugs. Therefore, RPS2P1 is a noncoding pseudogene, not a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S2 pseudogene 1 (RPS2P1).